Glucocorticoid receptors (GR) are present at a high density in the nucleus of the solitary tract (NTS), an area of the dorsal hindbrain (DHB) that is critical for blood pressure regulation. However, whether these receptors play any role in the regulation of blood pressure is unknown. We tested the hypothesis that glucocorticoids act in the DHB to increase arterial pressure using two experimental strategies. In one approach, we implanted pellets of corticosterone (Cort) or sham pellets onto the DHB over the NTS. Compared to rats with sham pellets, rats with DHB cort pellets had increased (P<0.05) mean arterial pressure (111±2 vs. 104±1 mmHg) and heart rate (355±9 vs.
Introduction
Glucocorticoids are important for the maintenance of normal baseline arterial pressure in both rats and humans. Adrenal insufficiency or blockade of glucocorticoid type II receptors (GR) can lower blood pressure (18, 22, 61) . The effects of adrenalectomy to lower blood pressure can be reversed by glucocorticoid, but not mineralocorticoid, replacement (61) . It is also established that elevated glucocorticoids produce dose-related increases in arterial pressure, and sufficiently high levels of glucocorticoids, due to either exogenous administration or endogenous overproduction will cause hypertension in both experimental animals and humans (22, 43, 44, 54) .
Long-term administration of glucocorticoids, commonly prescribed due to their antiinflammatory and immunosupressive therapeutic effects, results in a 20% incidence of iatrogenic hypertension (23) . There is also increasing evidence that prolonged mild elevations in glucocorticoids or increased sensitivity to the actions of glucocorticoids promote the development and maintenance of essential hypertension. Several studies have reported elevations in plasma and/or urinary glucocorticoids in essential hypertension (35, 55, 67, 68) . Advances in medical imaging have lead to the unanticipated discovery of small adrenal adenomas, termed "incidentalomas." in 2-9% of patients undergoing imaging for reasons other than symptoms of cortisol excess.
Investigation of this patient population revealed a significant increase in plasma cortisol, impaired feedback inhibition of cortisol release, and a 48% incidence of mild to severe essential hypertension (42) . The fact that not all studies of hypertensive patients report significant increases in glucocorticoids is likely due to the fact that multiple genetic and environmental factors contribute to the etiology of essential hypertension, such that the causes of hypertension vary among patient populations. Additionally, the protocols used to measure plasma glucocorticoids can influence the results. Glucocorticoid plasma concentrations vary by time of day, stress level and food intake, so plasma glucocorticoids must be measured using a controlled and consistent protocol in order to detect between-group differences (11, 27) . Even in the absence of measured elevations in glucocorticoid concentrations, alterations in glucocorticoid metabolism that can lead to increased tissue exposure to glucocorticoids have been reported in 4 essential hypertension (10, 55, 66, 68) . Finally, prenatal exposure to elevated glucocorticoids increases both glucocorticoid levels and the risk of hypertension in adulthood (6, 49) . Data from experimental animals further support a role for glucocorticoids in the development of hypertension (8, 25, 26, 28, 36, 57, 65) .
There are also genetic links between glucocorticoid receptors (GR) and human hypertension. Watt et al (67) reported that 27% of a group of patients with essential hypertension whose parents also had essential hypertension were homozygous for a 4.5-kb allele of the GR gene. This allele also associates with insulin resistance, increased body mass index and elevated cortisol levels (41, 62, 67) . Other variants of the GR gene have been associated with hypertension and/or coronary artery disease (30, 31) .
The mechanism of glucocorticoid-mediated effects on blood pressure remains both controversial and poorly understood. Most work has focused on effects of glucocorticoids in the periphery (7, 63 ). These studies demonstrate that glucocorticoids can modulate vascular reactivity to increase peripheral resistance. However, it is not clear that these vascular changes alone can account for the hypertensive effects of glucocorticoids. Little is known regarding the effects of glucocorticoids on central nervous system regulation of blood pressure. Several investigators have administered glucocorticoid agonists by intracerebroventricular (ICV) infusion (21, 60) or single injection (58, 64) and measured arterial pressure, but the results have been inconsistent. No studies have combined chronic delivery of glucocorticoids or GR antagonists to specific areas in the central nervous system with the measurement of blood pressure or heart rate.
We have selected the dorsal hindbrain (DHB) as the focus of these studies because of its key role in blood pressure regulation (56) . For example, the baroreceptor reflex is an essential mechanism of blood pressure regulation that is mediated by a pathway which includes DHB structures (56) , and systemic elevations in glucocorticoids attenuate the buffering capacity of the baroreceptor reflex (45, 48, (50) (51) (52) . Furthermore, GR are present in the DHB, particularly in the nucleus of the solitary tract (NTS), and the catecholaminergic neurons of the NTS contain one of the highest densities of GR in the brain (1, 16, 24) .
The present study used a new technique, developed in our lab, of chronic localized application of the endogenous glucocorticoid corticosterone (Cort) or the GR antagonist Mif to the DHB to test two interrelated hypotheses. The first hypothesis was that chronic elevations in DHB glucocorticoid levels increase arterial pressure. The second hypothesis was that chronic blockade of DHB GR would decrease arterial pressure in rats with glucocorticoid-induced elevations in arterial pressure. Glucocorticoids bind to two distinct receptor types: type I or mineralocorticoid receptors, (MR) that also bind aldosterone, and type II or glucocorticoid receptors, (GR) that are selective for glucocorticoids (39) . We focused on the actions of Cort mediated by the GR, since we were studying effects of increases in Cort, and the high affinity MR are almost fully occupied at even low levels of Cort (33) . 
Methods

Data
Surgical Procedures
All surgical procedures were performed using aseptic technique under a surgical plane of anesthesia as indicated by the absence of a withdrawal reflex to pinch of the hindpaw and of any reflex response to surgical manipulation. For the first surgical procedure rats were anesthetized with inhaled isoflurane (Aerrane, Henry Schein), and systemic increases in Cort were produced by subcutaneous implantation of 2 Cort pellets weighing approximately 100 mg each using a previously described technique (53) . Sham surgery was performed in rats that did not receive systemic Cort. Ten to 11 days later rats were anesthetized with Domitor (0.5 mg/kg ip medatomidine hydrochloride; Pfizer Animal Health, Exton PA) and ketamine hydrochloride (75 mg/kg ip) (13) and prophylactic antibiotic was administered (Pro-Pen-G, 600,00 U/kg intramuscular, Henry Schein). An arterial catheter was implanted into the femoral artery and exteriorized at the neck as previously described (45) . Each animal was then positioned in a stereotaxic apparatus with its head ventroflexed at a 60 o angle and a medial incision was made to expose the surface of the dura. A small hole was made through the atlanto-occipital membrane to visualize the dorsal surface of the hindbrain including the area postrema. After the pia mater was removed, the pellet was positioned on the midline with approximately 2/3 of its width rostral to the calamus scriptorius. The bottom surface of the pellet was first coated with a thin layer of mineral oil to provide a lipophilic interface between the pellet and the dorsal surface of the brain.
After placement on the brain surface, the pellet was covered with a small drop of surgical glue (Vetbond, Henry Schein) to keep it in place, followed by a small drop of silicone gel (Kwik-Sil, World Precision Instruments) to limit diffusion of the pellet contents into the cerebral spinal fluid. After the pellet was in place and covered with glue and silastic gel, a small piece of cellulose membrane (Data Sciences International) was glued over the hole in the atlanto-occipital membrane, and the skin incision was sutured closed. To control for systemic diffusion of Cort and Mif from the DHB pellets, in some animals Cort or Mif pellets were implanted on the surface of the dura. A small drop of surgical glue was used to hold the dura pellet in place. Each animal was given Antisedan (1mg/kg sc atipamezole hydrochloride) to reverse the anesthesia. Separate groups of rats were used for immunohistochemical detection of the occupied GR to visualize spread of Cort and Mif from DHB pellets. These rats were adrenalectomized to eliminate endogenous Cort. Adrenalectomy was performed under isoflurane anesthesia through a small dorsal incision. Rats were then given both 0.45% saline and 7% sucrose to drink ad libitum
Experimental Protocol
Each morning for 4 days following implantation of the DHB pellets and arterial catheters, rats were brought to the laboratory, usually between 8:30 and 9:30 AM, in their home cages. The arterial catheter was connected to a transducer via extension tubing with enough slack so that the animal was free to move about the cage. The signal from the transducer was processed using a bridge amplifier and MacLab data acquisition system. Mean arterial pressure and heart rate were calculated online. The rats were allowed a minimum of 2 h to acclimate to the laboratory setting, then the cardiovascular data used for analysis were collected for 1 hour. These experiments were performed in 7 groups of rats. Four of the 7 groups of rats received systemic (3, (45) (46) (47) (48) , so adrenal weights were determined in adrenal-intact rats at the conclusion of the experiments to measure systemic effects of Cort.
Immunohistochemistry
Immunohistochemistry for the occupied GR was used to demonstrate that steroid from the pellets was delivered to DHB nuclei involved in cardiovascular regulation, and to estimate the extent to which steroid from the pellets diffused to the ventral hindbrain and forebrain. We used a protocol developed in the labs of Drs. Susan Akana and Mary
Dallman at the University of California, San Francisco (2, 29) . Following the binding of either Cort or Mif to the GR, the ligand-receptor complex translocates to the nucleus (14, 38) . Using a rabbit anti-GR antibody (Affinity Bioreagents, #PA1-511) that has higher affinity for the occupied than for the unoccupied GR, dark punctate nuclear Sections were kept on a rocker for all incubation and rinsing steps, and were kept at room temperature unless otherwise noted. To reduce background staining, the sections were incubated in a mixture of 10% methanol, 3% hydrogen peroxide and TBS for 20 min. Sections were incubated in the primary antibody (1:1000 rabbit anti-GR, catalog #PA1-511A, Affinity Bioreagents) in TBS, gelatin, and 0.5% Triton-X 100,) overnight at Values for mean arterial pressure, heart rate, adrenal weight, plasma Cort and body weight were analyzed by analysis of variance and Duncan New Multiple Range posthoc analysis for between subjects differences. Due to occasional catheter malfunctions, cardiovascular data were not obtained in every animal on all 4 days, therefore data from each day were analyzed separately using between-subjects ANOVA. Data are presented as mean ± standard error. Significance was accepted at P<0.05.
Results
Rats used for measurement of cardiovascular parameters weighed an average of 315±5 g on the day systemic Cort pellets were implanted or sham surgery was performed, with no significant differences in body weight between experimental groups.
On the day DHB or dura pellets and catheters were implanted, rats with systemic Cort treatment weighed significantly less (296±8 g) than rats who had undergone sham surgery for systemic treatment (380±5 g). There were no significant effects of DHB or dura Cort or Mif pellets on body weight relative to DHB sham pellets.
In rats with normal systemic Cort levels, DHB Cort significantly increased mean arterial pressure and heart rate relative to DHB sham treatment after 4 days (Figure 1 , *=P<0.05). In contrast, the same Cort pellet placed on the dura had no effect on mean arterial pressure or heart rate, indicating that the DHB Cort was not altering these variables due to leakage into the periphery. DHB Mif had no effect on arterial pressure or heart rate, suggesting that dorsal DHB GR do not modulate baseline arterial pressure and heart rate under resting conditions during the day when glucocorticoid levels are near their nadir.
In rats with DHB sham treatment, systemic Cort treatment significantly increased mean arterial pressure (*=P<0.05, Figure 2 , top). DHB Mif significantly reduced mean arterial pressure in rats with systemic Cort treatment ( †=P<0.05). Mif pellets implanted on the dura had no effect on mean arterial pressure. There were no differences in heart rate among the groups (Figure 2 , bottom), except that heart rate was significantly 
Antagonizing Actions of Glucocorticoids using Mif
The GR antagonist Mif also blocks progesterone receptors (37) . However, we have previously shown that adrenalectomy eliminates the effect of Mif on baseline arterial pressure and heart rate, indicating that in male Sprague-Dawley rats it is acting as a selective GR receptor antagonist (45) . Furthermore, in the present study, DHB Mif decreased baseline arterial pressure in rats with elevated systemic Cort, but not in rats with normal systemic Cort levels, suggesting that Mif is selectively blocking effects of Cort. It is possible that the actions of Cort in the DHB are also mediated in part by MR receptors. 11-ß-hydroxysteroid dehydrogenase 2, an enzyme that limits access of Cort to MR by metabolizing Cort (15), is present in the NTS, but does not appear to be entirely co-localized with MR receptors (39, 40) .
Potential Mechanisms of Action for Glucocorticoids within the DHB
Three structures in the DHB participate in cardiovascular regulation: the nucleus of the solitary tract (NTS), the area postrema and the dorsal motor nucleus of the vagus (DMN). Within the DHB, we found no evidence that GR are present in the area postrema, but consistently observed intense staining for GR in the NTS of the positive control rats, in agreement with previous studies (1, 16, 24) . The DMN is positive for GR immuno-staining (1). In cats, vagal efferents projecting to the heart from the DMN appear to primarily modulate contractility, while cardiac vagal efferents controlling heart rate originate in the more ventral nucleus ambiguus (20) . If this is true in rats as well, glucocorticoids acting within the DHB to modulate cardiovascular control are most likely acting at GR in the NTS, with some contribution from the DMN. However, further experiments are required to determine the site of action of Cort within the DHB.
Baroreceptor and other visceral afferents terminate in NTS where the information regarding prevailing arterial pressure is processed and integrated with information from other sensory afferents and central projections (12) . Efferent projections from the NTS mediate reflex control of sympathetic nerve activity to the vasculature as well as sympathetic and vagal control of heart rate (4). We have previously reported that systemic increases in Cort elevate the midpoint and reduce the gain of the baroreceptor reflex. DHB Cort increased both arterial pressure and heart rate, suggesting the possibility that it produced alterations in baroreflex function similar to systemic Cort. In fact, we have reported preliminary findings that DHB Cort increases the midpoint of baroreflex control of heart rate (5). However, the idea that changes in baroreflex function can alter long-term regulation of blood pressure is controversial. Arterial baroreceptor denervation (SAD) rapidly increases resting arterial pressure and arterial pressure variability (56) . Several days after SAD, although arterial pressure variability remains high, average arterial pressure returns to near-normal, a fact that has been interpreted by many investigators as evidence that the arterial baroreceptor reflex does not play a role in the long-term regulation of arterial pressure. However, it is now accepted that the central nervous system has neuroplasticity and the data can be Immunohistochemistry for the occupied GR demonstrated that Cort and Mif from the DHB pellets were binding to GR in the DHB. This technique has been used in previous studies (2, 29) , and is useful to demonstrate the presence of either Cort or Mif in central nervous system regions that contain GR. Neurons in the ventral lateral medulla express GR and are important for the control of sympathetic nerve activity (16, 19, 24) .
Therefore, diffusion of Cort or Mif from the DHB to the ventral lateral medulla could potentially account for their effects on arterial pressure and heart rate. However, we observed primarily cytoplasmic and background staining in the ventral lateral medulla of adrenalectomized rats with DHB sham, Cort or Mif pellets, in contrast to the nuclear staining in the positive controls. There did appear to be some light nuclear staining in the hippocampus in the adrenalectomized rats with DHB Cort or Mif pellets (see Fig 6) .
With the exception of some of the immunohistochemistry, experiments were performed in adrenal-intact rats with normal or elevated plasma Cort levels, and it is extremely unlikely that in adrenal-intact rats Cort or Mif diffusing from the DHB pellets could occupy forebrain receptors in sufficient quantity to produce physiological effects, 
